Follow
Jason D Limberis
Title
Cited by
Cited by
Year
Xpert MTB/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results?
G Theron, R Venter, G Calligaro, L Smith, J Limberis, R Meldau, ...
Clinical Infectious Diseases 62 (8), 995-1001, 2016
1632016
Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable …
K Dheda, JD Limberis, E Pietersen, J Phelan, A Esmail, M Lesosky, ...
The lancet Respiratory medicine 5 (4), 269-281, 2017
1482017
Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa
O Olayanju, J Limberis, A Esmail, S Oelofse, P Gina, E Pietersen, M Fadul, ...
European respiratory journal 51 (5), 2018
1232018
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis
K Dheda, T Gumbo, G Maartens, KE Dooley, M Murray, J Furin, ...
The Lancet Respiratory Medicine 7 (9), 820-826, 2019
1062019
Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis
N Ismail, E Rivière, J Limberis, S Huo, JZ Metcalfe, RM Warren, A Van Rie
The Lancet Microbe 2 (11), e604-e616, 2021
402021
A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug-resistant tuberculosis
O Olayanju, A Esmail, J Limberis, K Dheda
European Respiratory Journal 55 (1), 2020
382020
Same-day tools, including Xpert Ultra and IRISA-TB, for rapid diagnosis of pleural tuberculosis: a prospective observational study
R Meldau, P Randall, A Pooran, J Limberis, E Makambwa, M Dhansay, ...
Journal of clinical microbiology 57 (9), 10.1128/jcm. 00614-19, 2019
372019
Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis
G Theron, J Limberis, R Venter, L Smith, E Pietersen, A Esmail, ...
Nature medicine 26 (9), 1435-1443, 2020
362020
A human lung challenge model to evaluate the safety and immunogenicity of PPD and live Bacillus Calmette-Guérin
M Davids, A Pooran, C Hermann, L Mottay, F Thompson, J Cardenas, ...
American journal of respiratory and critical care medicine 201 (10), 1277-1291, 2020
322020
Linezolid interruption in patients with fluoroquinolone-resistant tuberculosis receiving a bedaquiline-based treatment regimen
O Olayanju, A Esmail, J Limberis, P Gina, K Dheda
International Journal of Infectious Diseases 85, 74-79, 2019
282019
Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis
CC Naidoo, GR Nyawo, I Sulaiman, BG Wu, CT Turner, K Bu, Z Palmer, ...
EBioMedicine 67, 2021
252021
A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic
M Klopper, TH Heupink, G Hill-Cawthorne, EM Streicher, A Dippenaar, ...
BMC medicine 18, 1-14, 2020
242020
Selected questions and controversies about bedaquiline: a view from the field
K Dheda, A Esmail, J Limberis, G Maartens
The International Journal of Tuberculosis and Lung Disease 20 (12), S24-S32, 2016
152016
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
SB Georghiou, TC Rodwell, A Korobitsyn, SH Abbadi, K Ajbani, ...
European Respiratory Journal 59 (4), 2022
102022
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
B Derendinger, A Dippenaar, M de Vos, S Huo, R Alberts, R Tadokera, ...
The Lancet Microbe 4 (12), e972-e982, 2023
92023
Comparative performance of genomic methods for the detection of pyrazinamide resistance and heteroresistance in Mycobacterium tuberculosis
MG Whitfield, DM Engelthaler, C Allender, M Folkerts, TH Heupink, ...
Journal of clinical microbiology 60 (1), e01907-21, 2022
72022
High frequency of bedaquiline resistance in programmatically treated drug-resistant TB patients with sustained culture-positivity in Cape Town, South Africa
B Derendinger, A Dippenaar, M de Vos, S Huo, R Alberts, R Tadokera, ...
medRxiv, 2022.11. 14.22282167, 2022
52022
Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection
W Zheng, IC Chang, J Limberis, JM Budzik, BS Zha, Z Howard, L Chen, ...
bioRxiv, 2023
32023
uDumBell–Circularization of rv0678 for genotypic bedaquiline resistance testing of Mycobacterium tuberculosis
JD Limberis
12023
Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants
S Jaumdally, M Tomasicchio, A Pooran, A Esmail, A Kotze, S Meier, ...
Nature Communications 15 (1), 2003, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20